SCHEMBL6465319

SCHEMBL6465319

CCCCCCCC/C=C\CCCCCCCCC([C]=O)CCCCCCCCCCCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.52
TRPV1 Q8NER1 1/20 0.52
TERT O14746 3/20 0.46
PTPN1 P18031 3/20 0.46
PPARG P37231 3/20 0.46
PPARD Q03181 3/20 0.46
PPARA Q07869 3/20 0.46
CYP1A2 P05177 2/20 0.46
MAPT P10636 2/20 0.46
CYP2C19 P33261 2/20 0.46
BLM P54132 2/20 0.46
HSD17B10 Q99714 2/20 0.46
FABP4 P15090 2/20 0.46
KMT2A Q03164 2/20 0.46
TOP1 P11387 2/20 0.46
GMNN O75496 1/20 0.46
USP2 O75604 1/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6672341 1.00 FAAH (0.52) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9467075 1.00 FAAH (0.52) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL10583681 1.00 FAAH (0.52) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL15015524 1.00 FAAH (0.52) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9467020 1.00 FAAH (0.52) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL151797 1.00 FAAH (0.52) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9466962 0.98 FAAH (0.50) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9467790 0.96 FAAH (0.48) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL9118049 0.94 TRPV1 (0.52) TRPV1PPARGPPARDPPARAMAPT
SCHEMBL9467703 0.94 TRPV1 (0.52) TRPV1PPARGPPARDPPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3362048-A2 COMPOSITION FOR INTRAORAL DELIVERY OF BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS Pharcon Inc. (CA) 2018-08-22 EP claimed
WO-2017093810-A2 COMPOSITION FOR INTRAORAL DELIVERY OF BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS PHARCON INC. (CA) 2017-06-08 WO claimed
CN-117143492-A Release agent and preparation method thereof, release film and preparation method of release film 浙江永盛科技有限公司 2023-12-01 CN disclosed
EP-1596670-B1 OILS ENRICHED WITH DIACYLGLYCEROLS AND PHYTOSTEROL ESTERS FOR USE IN THE REDUCTION OF CHOLESTEROL AND TRIGLYCERIDES ENZYMOTEC LTD (IL) 2014-05-07 EP disclosed
EP-1596670-A2 OILS ENRICHED WITH DIACYLGLYCEROLS AND PHYTOSTEROL ESTERS FOR USE IN THE REDUCTION OF CHOLESTEROL AND TRIGLYCERIDES Enzymotec Ltd. (IL) 2005-11-23 EP disclosed
WO-2004084646-A2 COSMETIC COMPOSITIONS COMPRISING PHYTOSTEROL ESTERS ENZYMOTEC LTD. (IL) 2004-10-07 WO disclosed
WO-2004069150-A2 OILS ENRICHED WITH DIACYLGLYCEROLS AND PHYTOSTEROL ESTERS FOR USE IN THE REDUCTION OF CHOLESTEROL AND TRIGLYCERIDES ENZYMOTEC LTD. (IL) 2004-08-19 WO disclosed
EP-0767655-A4 METHODS OF TREATING HYPERTENSION AND OF IMPROVING IMPAIRED RENAL FUNCTION YISSUM RES DEV CO (IL) 1998-09-16 EP disclosed
EP-0767655-A1 METHODS OF TREATING HYPERTENSION AND OF IMPROVING IMPAIRED RENAL FUNCTION YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1997-04-16 EP disclosed
WO-1995034288-A1 METHODS OF TREATING HYPERTENSION AND OF IMPROVING IMPAIRED RENAL FUNCTION YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1995-12-21 WO disclosed